Clinical Trials Browser

Phase 2 × Melanoma × Vaccination × Clear all

NCT01042366 2017-08-16

Dendritic Cells (DC) Vaccine for Metastatic Melanoma

Phase 2 Terminated

16 enrolled 8 charts

Melanoma